PMR Research Reports

Demand for synthetic opioids continues to witness a decline in North America. According to a new research from Persistence Market Research, the US$ 75 billion synthetic opioids market will grow at a sluggish 2.4% during the period 2016-2024. Rising concerns about the addictive nature of opioids, combined with drug abuse has led to declining sales. According to the Centers for Disease Control and Prevention (CDC) around 33,000 Americans died from opioid overdose in 2015. The agency also reported that almost half of non-cancer patients who have been prescribed opioids for a month are still dependent on the pills a year later. Further, side effects of synthetic opioids, such as reduce libido, urinary difficulties, appetite loss, and spells of dizziness are also influencing sales negatively. To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/15898 According to Persistence Market Research, introduction of non-abuse opioid

According to a study conducted by Persistence Market Research (PMR), the global market for cryotherapy is set to witness a CAGR of 6.5% during the forecast period 2016-2024. According to the study, North America will continue to be the leading market for cryotherapy globally during the forecast period. Highlights from the Report Suppliers are emphasizing on ensuring affordable and adequate supply of gas in order to provide smoother maintenance services to clients, while steadily increasing the range of non-gas equipment. Higher investments in training programs on cryosurgical approach are anticipated to broaden the pool of skilled resources/surgeons. While growing popularity of minimally invasive procedures is propelling the demand for cryosurgery equipment, lack of information on treatment option and complex regulatory nature of cryosurgery equipment is likely to curb the overall market growth. For Detailed Insights On Enhancing Your Product Footprint, Request For A Sample Here

The latest report published by Persistence Market Research titled “ Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024 ". projects some of the crucial aspects of the global precision medicine market after an in-depth research. The report assures that the market will grow manifold and it will register a 14.7% CAGR between 2016 and 2024. Global Precision Medicine Market: The Propellers The global expansion of the medicine industry will expand the canvas of the global precision market. Larger investments, better infrastructure, simplified approval process of drugs along with companion diagnostics will impact the structure of the entire climate of the global precision medicine market. The affordable DNA profiling, the bloating cancer population of the globe will create a favorable condition of growth for the global precision medicine market. The proper storage of genome data plays a cru

According to the latest market report published by Persistence Market Research titled “ Global Fluoroscopy & C – Arms Market: Industry Analysis and Forecast, 2016 – 2024 ”, the global Fluoroscopy and C – Arms market is expected to exhibit a CAGR of 4.5% during the forecast period 2016–2024. In the report, Persistence Market Research provides a detailed analysis of the global market performance and throws light on the key factors and trends likely to influence the global Fluoroscopy and C – Arms market over an eight-year forecast period. Key market drivers and trends Rising prevalence of cardiovascular diseases and adoption of minimally invasive surgeries along with the adoption of new technology such as flat panel detectors are the major factors driving the growth of the global Fluoroscopy and C – Arms market. Other market growth drivers include the introduction of low priced C – Arms and a growing awareness of interventional surgeries in emerging economies. Furthermore, a strate

Persistence Market Research (PMR) delivers key insights on the Global Opioids Market in its latest report titled “ Global Market Study on Opioids: Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period  ”.The global opioids market is anticipated to exhibit a stable CAGR during the forecast period (2015-2021). By product type, the global opioids market is segmented into morphine, codeine, fentanyl, meperidine and methadone. Morphine segment was the largest contributor in overall opioids market, accounting for around 36% share in 2014. However, fentanyl segment is expected to register fastest CAGR of 4.7% during the forecast period. Synthetic opioids such as fentanyl, meperidine and methadone have lucrative growth opportunities in opioids market, owing to their potential application in opioid substitution treatment and fewer side effects as compared to natural opioids. By application, the global opioids market is segmented into analgesia

According to a new market report published by Persistence Market Research “ Global Market Study on Neurostimulation Devices - Deep Brain Stimulation Devices to Witness Highest Growth by 2020 ,” the global neurostimulation devices market was valued at US$ 5,088.9 Mn in 2014 and is expected to grow at a CAGR of 12.7% from 2014 to 2020, to reach US$ 10,445.7 Mn by 2020.   Neurostimulation technology involves the use of microelectrodes to activate elements of the nervous system. It involves the use of a neurostimulation device - a battery-powered stopwatch-sized device - which is surgically implanted in the brain and delivers electric signals at scheduled time intervals to the nervous system. These electric signals develop tingling sensations (paresthesia) in the damaged nerve and helps chronic pain and neurological disorders. In chronic pain conditions, these electric signals block the pain messages from the damaged nerve from reaching the brain. These devices are gaining importance in

According to a new market report published by Persistence Market Research “ Global Market Study on Compression Therapy - Asia to Witness Highest Growth by 2020 ”, the global compression therapy market was valued at USD 2,377.8 million in 2014 and is expected to expand at a CAGR of 5.2% from 2014 to 2020, to reach USD 3,232.3 million by 2020.   Compression therapy is a procedure entailing the delivery of an external force to tired and aching legs and other relevant anatomical targets where compression is required for management. This therapy is used to treat venous and lymphatic diseases such as lower limb edema, venous eczema, deep vein thrombosis, and diabetic foot ulcers.    Globally, the market for compression therapy is witnessing significant growth due to the increasing prevalence of diabetes, growth of the aging population, high incidence of sports injuries, rising awareness about various venous diseases, and the advanced features of compression therapy garments and devices.

According to a new market report published by Persistence Market Research  “ Global Market Study on Cranio Maxillofacial Implants: Asia to Witness Highest Growth by 2020 ” the global cranio maxillofacial implants market was valued at USD 1,044.7 million in 2014 and is expected to grow at a CAGR of 6.2% from 2014 to 2020, to reach an estimated value of USD 1,498.6 million in 2020.   Cranio maxillofacial surgery refers to a procedure for treatment of a severe injury to the cranial and facial bones. Treatment of injured cranial and facial bones usually requires internal fixators such as plate and screw fixation systems, flap fixation devices, bone graft substitutes or others to fix the facial fracture. Globally, the cranio maxillofacial implants market is witnessing significant growth due to increasing incidence of facial fractures and emergence of new procedural techniques and positive clinical outcome. In addition, increased healthcare expenditure and lack of substitutes are driving t

According to a new market report published by Persistence Market Research “ Global Market Study on Dental Implants - Asia Pacific to Witness Fastest Growth by 2020 ,” the global Dental implants market was valued at USD 4,508.9 million in 2014 and is expected to grow at a CAGR of 9.7% from 2014 to 2020, to reach an estimated value of USD 7,879.5 million in 2020.   Globally, rising aging population has increases the demand for dental implants in the market. As a result, the market is expected to grow at a CAGR of about 9.7% from 2014 – 2020.   Some of the major drivers which help in increasing demand for dental implants are rising aging population and growing concern for oral healthcare. Rising demand for cosmetic dentistry also supports the growth of dental implants market. High cost of dental implants surgery in countries such as the U.S. and the U.K. supports the growth of medical tourism in different part of the world including Malaysia, Hungary, Costa Rica, and India. However, l

Market consolidation strategies to be centered around acquisition of key technologies and specialty pharma companies. Solid dosage continues to remain the most preferred drug delivery form, used across a wide spectrum of pharmaceutical landscape, pushing the global  oral solid dosage (OSD) contract manufacturing market  to a promising US$ 21.5 Billion cap, in 2019, predicts Persistence Market Research, in its recently released study on the global oral solid dosage contract manufacturing landscape. Apart from being more cost-effective (compared to the novel treatment alternatives and increasing number of biologics) and patient complaint, oral dosage provides increased physical and chemical stability, controlled-release options, and superior ease of handling. The global oral solid dosage contract manufacturing market is estimated to grow at a high CAGR of 5.8 percent, through the forecast period of 2017-2028. “ The market will continue to perform immensely well, given the unrivaled dem

Catering to a niche population, the global demand for facial bone contouring is expected to remain rather sluggish, through 2019—risks and complications associated with surgeries, premium pricing, and lack of trained professionals being the top three market restrainers. Likely revenue generated through facial bone contouring procedures, carried out globally, is projected to reach a revenue of US$ 409.4 Mn, in 2019, representing an annual growth of 1.9 percent, as indicated by a recently released market study by Persistence Market Research (PMR), covering the facial bone contouring landscape. PMR offers a comprehensive analysis of the global facial bone contouring market, for a timeline of eight years, 2018-2026. “Most of the appearance enhancement surgeries are known to be carried out in USA, Brazil, Japan, Mexico and Italy, followed by Thailand, Germany, and Colombia. On the other hand, surgeons associated with America Society of Plastic Surgeons—suggest substantial increase in the n

The global demand for dental lasers is anticipated to grow moderately, in 2019, representing a growth rate of approximately 4.5 percent. As per a recently released in-depth analysis of the global dental lasers adoption by Persistence Market Research, the  dental lasers market  is expected to exceed the valuation of US$ 409 Mn—the market growth rate standing at 1.4X, through the assessment period of 2018-2026. “The growing demand rate can safely be attributed to exploding laser application to treat dental diseases, including restorative removal and curing, caries prevention, dentinal hypersensitivity, cavity preparation, growth modulation, and other diagnostic purposes—all constituting hard tissue applications. Dental lasers have also found increased adoption in soft tissue application comprising wound healing, photodynamic therapy for malignancies, removal of hyperplastic tissue, and photostimulation of herpetic lesion. Apart from demonstrated procedure specificity, dental lasers have

The FDA recently approved Oxymetazoline, employed in the rosacea-related persistent facial erythema in adults. Soolantra (topical ivermectin) received the FDA approval recently, for the use in the treatment of inflammatory lesions of rosacea. The FDA’s approval for a topical cream RHOFADE (Oxymetazoline Hydrochloride) paved the way for the drug in the rosacea therapeutics, exclusively for persistent facial erythema in adults. A tentative approval by the FDA has allowed the inclusion of Zenavod capsules (doxycycline) in rosacea therapeutics. These capsules are particularly used against pustules and papules, i.e. the specific inflammatory lesions associated with the condition in adults. While these FDA approvals for rosacea therapeutics were registered in 2017, the decently growing rate of the introduction of new FDA-approved drugs is likely to provide a strong push to the revenue expansion of rosacea therapeutics landscape. With an expanding rosacea patient pool, most prominently

Anticipated to surpass the US$ 20 Billion mark in 2019, generic oncology drugs will witness increased demand in the coming years Increased spending in cancer-related research and development by various governments and private and commercial organizations combined with investments in anti-cancer drugs are the two key factors anticipated to heighten the generic oncology drugs demand, through 2019, as indicated in a recent market analysis of generic oncology drugs, by Persistence Market Research (PMR).  Expanding at a robust annual rate of over 6.1 percent, the global revenue through sales of generic oncology drugs will surpass US$ 23 Billion in 2021. “ PMR estimates that notable product pipeline for generic oncology drugs is expected to drive lucrative business opportunities. Moreover, with industry’s pipeline reaching a historic level of late-stage development, in 2017, almost 90% of the therapies being targeted treatments and clinical success rates going up to almost 73 percent, the

Considered as the first line of treatment for arrhythmias, demand for electrophysiology ablation procedures is projected to increase 2X Lying in the high growth-low revenue quadrant, the global electrophysiology ablation market is anticipated to expand at a stellar annual growth rate of 9.1 percent, standing at a valuation of US$ 2.3 Billion by 2019 end, as per a recent market analysis by Persistence Market Research. The growing demand for electrophysiology (EP) is attributed to the advancing EP technologies with new ablation tools to improve atrial fibrillation (AF) treatments. Moreover, implantable rhythm management devices for less invasive procedures combines with miniaturized diagnostic monitoring systems are also pumping revenue into the global electrophysiology ablation market. In addition, electrophysiology ablation being the first line of treatment for arrhythmias, considered superior to antiarrhythmic drugs, is anticipated to be a key factor contributing to the electrophysio

Rapid advancements taking place in the healthcare sector in North America are pushing revenues across medical devices markets. The region has witnessed a growth in the adoption of aneurysm clips to treat aneurysm, leading to a steady rise in revenue in the North America aneurysm clips market. Asia Pacific Excluding Japan (APEJ) is the second most prominent region in the aneurysm clips market, with China anticipated to be the most lucrative regional market within APEJ. According to a new research released by Persistence Market Research (PMR), the market for aneurysm clips in matured economies will record comparatively lesser growth than in emerging markets. PMR forecasts indicate a steady growth in revenue in the global aneurysm clips market at a sluggish rate of 1.7% during 2018–2028. Global revenue is slated to reach US$ 21.5 Mn by the end of 2018. To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/25471 The report

Increase in the number of dental clinics in developed countries plays a significant role in the growth of the dental preventive supplies market. Various activities and programs, which support the dental preventive measures, are also expected to drive the growth of the dental preventive supplies market. Increased awareness regarding oral diseases and prevalence of dental caries mainly due to unhealthy lifestyle, smoking, and excessive consumption of alcohol among the young population also play a vital role in boosting the growth of the dental preventive supplies market. There is an increase in the demand for dental products among graying population, which creates enormous growth opportunities for the manufactures in the dental preventive supplies market. An increase in the demand for dental products among graying population creates enormous opportunities for the manufactures. Improved life expectancies of graying population is also expected to be a driving factor for the growth of the d

A large number of humanized liver mice models are available, including uPA-SCID mice, FRG KO mice, and TK-NOG mice, among others. Factors such as increasing incidence of liver cirrhosis, technological advancement and development of new humanized liver mice models, increase in number of FDA approvals for liver-based disease treatment dugs have increased the number of research and development activities, which require these models. However, the high cost of mice models as well as high shipping cost, and availability of alternatives are factors expected to hinder the growth of the humanized liver mice model market during the forecast period. Furthermore, regulatory challenges including patenting of mice and other ethical issues including the use of 3Rs policy are also expected to restrain the growth of the humanized liver mice model market. The global humanized liver mice model market is projected to account for over US$ 22.8 Mn in terms of value by 2026 end, according to a latest researc

According to the American Sleep Association, around 50-70 million adults in the U.S. are suffering from sleep disorders, 48.0% of the U.S. adults report snoring, and approximately 5.9 million U.S. adults were diagnosed with obstructive sleep apnea (OSA). In Latin America, the prevalence of OSA was 23.5% in 2013. Sleep aid devices are considered as useful tools for the treatment of sleep disorders. According to the latest research by Persistence Market Research (PMR), the global sleep aid devices market is anticipated to account for over US$ 29,200 Mn, in terms of value, by 2026 end. The report on the sleep aid devices market further projects significant growth potential with CAGR at 4.9% through 2026. Rising stress levels and the rapid increase in sleep disorders such as, insomnia, sleep apnea, restless legs syndrome, narcolepsy, and sleep deprivation have created a need for more advanced sleep aid devices. Various government and non-government organizations such as Circadian Sleep Di

While road accidents are projected to become the seventh leading cause of death by the end of 2030, WHO also points to a growing number of traumatic instances due to road accidents. On the other side, ASIRT (the Association of System Integrators and Retailers in Technology) says that road accidents injure approximately 50 million people, yearly – translating into severe orthopedic injuries. In addition, accidents in the field of athletics lead to major or minor orthopedic injuries. Small joint injury forms a major part of the total orthopedic injury scenario, thereby generating the need for small joint replacement therapies. A few more factors that play an important role in raising the demand for small joint replacement include aging, severe calcium deficiency, a growing number of low bone density cases, and increasing instances of arthritis and osteoporosis. To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/259